LEXTF Financials
Lexston Life Sciences Corp - Financial statements & key metrics
Stock Price
$0.04
Market Cap
$944,512
EPS
$-0.11
Income Statement Highlights
Most Recent Quarter: 2024-05-31
Revenue
$0.00
Gross Profit
-
Operating Income
$-734282.00
Net Income
$-867713.00
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$750949.00
Total Liabilities
$39869.00
Shareholders Equity
$711080.00
Cash & Equivalents
$390405.00
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-523178.00
CapEx
$199985
Free Cash Flow
$-723,163
Profitability Metrics
ROE
-1.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LEXTF revenue?
LEXTF's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is LEXTF profitable?
LEXTF reported a loss of $867,713 in the most recent quarter.
What is LEXTF market cap?
LEXTF has a market capitalization of $944,512, making it a small-cap stock.
Does LEXTF have debt?
View LEXTF's balance sheet for debt information.
What is LEXTF cash flow?
LEXTF's most recent quarterly free cash flow was $-723,163.